ArticleAdvanced biomedical research2026
Can Variations in the Diet Quality Index Over Five Years Improve Renal Function and Lipid Profiles Among Patients with Type 2 Diabetes Mellitus? Results from the Prospective Azar Cohort Study.
Article in Advanced biomedical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Type 2 diabetes mellitus (T2DM) is associated with complications, including chronic kidney disease (CKD) and dyslipidemia. This prospective study investigated the longitudinal relationship between changes in diet quality, assessed using the Diet Quality Index-International (DQI-I), and alterations in kidney biomarkers and lipid profiles among patients with T2DM over 5 years. Materials and Methods: A cohort of 102 patients with T2DM participated. Diet quality was evaluated at baseline and after 5 years using a validated, 130-item semiquantitative food frequency questionnaire (FFQ). Concurrently, fasting blood samples were collected to measure biomarkers: Fasting blood sugar (FBS), creatinine (Cr), blood urea nitrogen (BUN), glomerular filtration rate (GFR), cholesterol, triglycerides (TG), low-density lipoprotein cholesterol (LDL), and high-density lipoprotein cholesterol (HDL). Regression models analyzed associations between changes in DQI-I scores and changes in these biomarkers. Results: DQI-I scores demonstrated a statistically significant increase over the 5-year period. However, these improvements in diet quality showed no significant association with favorable changes in kidney biomarkers (Cr, BUN, GFR) or lipid profiles (TG, LDL, HDL, cholesterol). The findings indicate that while dietary quality improved, this did not translate into significant effects on lipid metabolism or kidney function parameters. Conclusion: Despite observed improvements in overall diet quality, no significant improvements in lipid profiles or kidney biomarkers were detected. These results underscore the complexity of managing T2DM and its associated complications through dietary modification alone. Future research employing larger sample sizes and extended durations is warranted to elucidate further the long-term impact of dietary changes on renal function and lipid homeostasis in T2DM populations.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.